ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $1,243,000 | -45.2% | 30,755 | -21.9% | 0.00% | -40.0% |
Q2 2015 | $2,268,000 | -2.0% | 39,398 | +8.4% | 0.01% | +25.0% |
Q1 2015 | $2,315,000 | +484.6% | 36,354 | +466.5% | 0.00% | +300.0% |
Q4 2014 | $396,000 | -5.0% | 6,417 | -47.0% | 0.00% | 0.0% |
Q2 2014 | $417,000 | – | 12,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |